Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Resistance news

Show

From To
Spanish study gives reassurance: small HIV blips do not predict treatment failure

A very low viral load (20-49 copies/ml) during HIV therapy does not increase the risk of the subsequent virological failure of treatment (viral load above 200 copies/ml), according

Published
21 September 2016
By
Michael Carter
Four day a week ART: sub-optimal drug levels but few virological failures

A poster at IAS 2016 reported on the effectiveness of a strategy in France to use reduced dose maintenance therapy. This involved only taking ART for four rather than seven days a week.

Published
20 September 2016
From
HIV i-Base
Most people taking second-line ART in sub-Saharan Africa achieve viral suppression but there's a need for third-line treatment options

Approximately 85% of people switched to protease inhibitor-based second-line antiretroviral (ART) in sub-Saharan Africa achieve and maintain an undetectable viral load with their new regimen, according to research

Published
12 August 2016
By
Michael Carter
Think the Aids epidemic is over? Far from it – it could be getting worse

The 2000 Aids conference in Durban shocked the world into action. Now, a new crisis looms, one fuelled by drug resistance, costly treatments and the lack of power many women have in sexual relationships.

Published
31 July 2016
From
The Guardian
Hope for 'end of Aids' is disappearing, experts warn

Those fighting epidemic say 2030 target is unrealistic as efforts to defeat it falter amid rising infection levels and drug resistance.

Published
31 July 2016
From
The Guardian
WHO flags key challenges to global HIV response at International AIDS Conference

The World Health Organization is highlighting the need to renew attention to HIV prevention, whilst maintaining momentum on scaling up access to HIV treatment. It is also signalling the growing emergence of antiretroviral (ARV) drug resistance and the need for sustainable financing of the global response.

Published
17 July 2016
From
WHO
Very high levels of drug resistance seen in people experiencing first-line antiretroviral therapy failure in Kenya

A cross-sectional survey of viral load in patients attending the largest HIV clinic in Kenya has shown that after an average of nearly two years

Published
31 May 2016
By
Gus Cairns
HIV rapidly develops resistance to gene-editing cure technology

In a setback for a novel approach to curing HIV, researchers involved in a technique that uses enzymes to remove viral genes from the DNA of infected

Published
17 May 2016
By
Gus Cairns
Outbreak of high level azithromycin resistant gonorrhoea in England

There have been 34 cases of high level azithromycin resistant gonorrhoea amongst residents of England between November 2014 and April 2016. The outbreak spread from the north of England to the West Midlands and south of England, including London. Initial cases were among heterosexuals but more recent evidence suggests high level azithromycin resistant gonorrhoea is now spreading among men who have sex with men.

Published
15 April 2016
From
Public Health England
Resistance to anti-HIV drugs in steep decline in Switzerland

Prevalence of antiretroviral drug resistance has declined significantly among patients in Switzerland, investigators report in the online edition of Clinical Infectious Diseases. As many as 57% of

Published
13 April 2016
By
Michael Carter
← First12345...33Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close